Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 01-Apr-24 9:30 PM View:  | Forte Steve EVP, Chief Financial Officer | Repare Therapeutics Inc. (RPTX) | 01-Apr-24 | Sale (Planned) | 789 | $4.61 | $3,637.29 | (2%) 45.56K to 44.77K | |
| 01-Apr-24 9:31 PM View: | Segal Lloyd Mitchell President and CEO Director | Repare Therapeutics Inc. (RPTX) | 01-Apr-24 | Sale (Planned) | 2,491 | $4.63 | $11,533.30 | (1%) 212.73K to 210.24K | |
| 01-Apr-24 9:27 PM View: | Koehler Maria EVP, Chief Medical Officer | Repare Therapeutics Inc. (RPTX) | 01-Apr-24 | Sale (Planned) | 300 | $4.66 | $1,398.00 | (< 1%) 231.71K to 231.41K | |
| 01-Apr-24 9:28 PM View: | Zinda Michael EVP, Chief Scientific Officer | Repare Therapeutics Inc. (RPTX) | 01-Apr-24 | Sale (Planned) | 410 | $4.66 | $1,910.60 | (< 1%) 72.32K to 71.91K | |
| 01-Apr-24 9:31 PM View: | Segal Lloyd Mitchell President and CEO Director | Repare Therapeutics Inc. (RPTX) | 28-Mar-24 | Sale (Planned) | 2,650 | $4.62 | $12,243.00 | (1%) 215.38K to 212.73K | |
| 01-Apr-24 9:27 PM View: | Koehler Maria EVP, Chief Medical Officer | Repare Therapeutics Inc. (RPTX) | 28-Mar-24 | Sale (Planned) | 500 | $4.64 | $2,320.00 | (< 1%) 232.21K to 231.71K | |
| 01-Apr-24 9:28 PM View: | Zinda Michael EVP, Chief Scientific Officer | Repare Therapeutics Inc. (RPTX) | 28-Mar-24 | Sale (Planned) | 450 | $4.64 | $2,088.00 | (< 1%) 72.77K to 72.32K | |
| 01-Apr-24 9:30 PM View: | Forte Steve EVP, Chief Financial Officer | Repare Therapeutics Inc. (RPTX) | 28-Mar-24 | Sale (Planned) | 825 | $4.62 | $3,811.50 | (2%) 46.39K to 45.56K | |
| 27-Mar-24 6:57 PM View: | Zinda Michael EVP, Chief Scientific Officer | Repare Therapeutics Inc. (RPTX) | 27-Mar-24 | Sale (Planned) | 450 | $4.62 | $2,079.00 | (< 1%) 73.22K to 72.77K | |
| 27-Mar-24 6:59 PM View: | Forte Steve EVP, Chief Financial Officer | Repare Therapeutics Inc. (RPTX) | 27-Mar-24 | Sale (Planned) | 825 | $4.62 | $3,811.50 | (2%) 43.04K to 42.21K | |
| 27-Mar-24 6:54 PM View: | Segal Lloyd Mitchell President and CEO Director | Repare Therapeutics Inc. (RPTX) | 27-Mar-24 | Sale (Planned) | 2,650 | $4.63 | $12,269.50 | (1%) 211.19K to 208.54K | |
| 27-Mar-24 6:56 PM View: | Koehler Maria EVP, Chief Medical Officer | Repare Therapeutics Inc. (RPTX) | 27-Mar-24 | Sale (Planned) | 500 | $4.62 | $2,310.00 | (< 1%) 232.71K to 232.21K | |
| 27-Mar-24 6:59 PM View: | Forte Steve EVP, Chief Financial Officer | Repare Therapeutics Inc. (RPTX) | 26-Mar-24 | Sale (Planned) | 825 | $4.60 | $3,795.00 | (2%) 43.86K to 43.04K | |
| 27-Mar-24 6:56 PM View: | Koehler Maria EVP, Chief Medical Officer | Repare Therapeutics Inc. (RPTX) | 26-Mar-24 | Sale (Planned) | 500 | $4.60 | $2,300.00 | (< 1%) 233.21K to 232.71K | |
| 27-Mar-24 6:54 PM View: | Segal Lloyd Mitchell President and CEO Director | Repare Therapeutics Inc. (RPTX) | 26-Mar-24 | Sale (Planned) | 2,650 | $4.64 | $12,296.00 | (1%) 213.84K to 211.19K | |
| 27-Mar-24 6:57 PM View: | Zinda Michael EVP, Chief Scientific Officer | Repare Therapeutics Inc. (RPTX) | 26-Mar-24 | Sale (Planned) | 450 | $4.61 | $2,074.50 | (< 1%) 73.67K to 73.22K | |
| 27-Mar-24 6:56 PM View: | Koehler Maria EVP, Chief Medical Officer | Repare Therapeutics Inc. (RPTX) | 25-Mar-24 | Sale (Planned) | 500 | $4.78 | $2,390.00 | (< 1%) 233.71K to 233.21K | |
| 27-Mar-24 6:54 PM View: | Segal Lloyd Mitchell President and CEO Director | Repare Therapeutics Inc. (RPTX) | 25-Mar-24 | Sale (Planned) | 2,650 | $4.79 | $12,693.50 | (1%) 216.49K to 213.84K | |
| 27-Mar-24 6:57 PM View: | Zinda Michael EVP, Chief Scientific Officer | Repare Therapeutics Inc. (RPTX) | 25-Mar-24 | Sale (Planned) | 450 | $4.78 | $2,151.00 | (< 1%) 74.12K to 73.67K | |
| 27-Mar-24 6:59 PM View: | Forte Steve EVP, Chief Financial Officer | Repare Therapeutics Inc. (RPTX) | 25-Mar-24 | Sale (Planned) | 825 | $4.79 | $3,951.75 | (2%) 44.69K to 43.86K | |
| 04-Mar-24 9:06 PM View: | Zinda Michael EVP, Chief Scientific Officer | Repare Therapeutics Inc. (RPTX) | 01-Mar-24 | Grant | 14,000 | -- | -- | 23% 60.12K to 74.12K | |
| 04-Mar-24 9:02 PM View: | Koehler Maria EVP, Chief Medical Officer | Repare Therapeutics Inc. (RPTX) | 01-Mar-24 | Grant | 14,000 | -- | -- | 6% 219.71K to 233.71K | |
| 05-Mar-24 4:15 PM View: | Forte Steve EVP, Chief Financial Officer | Repare Therapeutics Inc. (RPTX) | 01-Mar-24 | Grant | 14,000 | -- | -- | 46% 30.69K to 44.69K | |
| 04-Mar-24 9:04 PM View: | Segal Lloyd Mitchell President and CEO Director | Repare Therapeutics Inc. (RPTX) | 01-Mar-24 | Grant | 40,000 | -- | -- | 22% 179.14K to 219.14K | |
| 12-Dec-23 4:19 PM View: | Koehler Maria EVP, Chief Medical Officer | Repare Therapeutics Inc. (RPTX) | 11-Dec-23 | Option Exercise | 43,746 | $2.26 | $98,755.10 | 25% 175.96K to 219.71K | |
| 17-Nov-23 4:54 PM View: | Bvf Partners L P/il 10% Owner | Repare Therapeutics Inc. (RPTX) | 16-Nov-23 | Purchase | 295,745 | $5.38 | $1,592,200.00 | 3% 9.87M to 10.17M | |
| 17-Nov-23 4:54 PM View: | Bvf Partners L P/il 10% Owner | Repare Therapeutics Inc. (RPTX) | 15-Nov-23 | Private Purchase | 931,556 | $5.00 | $4,657,690.00 | 10% 8.94M to 9.87M | |
| 03-Nov-23 5:37 PM View: | Bvf Partners L P/il 10% Owner | Repare Therapeutics Inc. (RPTX) | 02-Nov-23 | Private Purchase | 783,709 | $3.60 | $2,821,350.00 | 10% 8.16M to 8.94M | |
| 09-Jun-23 4:25 PM View: | Zinda Michael EVP, Chief Scientific Officer | Repare Therapeutics Inc. (RPTX) | 08-Jun-23 | Sale (Planned) | 2,869 | $12.02 | $34,485.40 | 5% 57.25K to 60.12K | |
| 09-Jun-23 4:25 PM View: | Zinda Michael EVP, Chief Scientific Officer | Repare Therapeutics Inc. (RPTX) | 07-Jun-23 | Sale (Planned) | 6,404 | $12.03 | $77,040.10 | (9%) 69.39K to 62.99K | |
| 07-Jun-23 4:55 PM View: | Zinda Michael EVP, Chief Scientific Officer | Repare Therapeutics Inc. (RPTX) | 06-Jun-23 | Sale (Planned) | 1,200 | $12.04 | $14,448.00 | (2%) 70.59K to 69.39K | |
| 01-Feb-23 9:44 PM View: | Forte Steve EVP, Chief Financial Officer | Repare Therapeutics Inc. (RPTX) | 30-Jan-23 | Grant | 24,530 | -- | -- | 398% 6.16K to 30.69K | |
| 01-Feb-23 9:44 PM View: | Segal Lloyd Mitchell President and CEO Director | Repare Therapeutics Inc. (RPTX) | 30-Jan-23 | Grant | 78,550 | -- | -- | 78% 100.59K to 179.14K | |
| 01-Feb-23 9:45 PM View: | Koehler Maria EVP, Chief Medical Officer | Repare Therapeutics Inc. (RPTX) | 30-Jan-23 | Grant | 26,450 | -- | -- | 18% 149.51K to 175.96K | |
| 01-Feb-23 9:46 PM View: | Zinda Michael EVP, Chief Scientific Officer | Repare Therapeutics Inc. (RPTX) | 30-Jan-23 | Grant | 24,550 | -- | -- | 53% 46.04K to 70.59K | |
| 03-Jan-23 4:38 PM View: | Jerel Davis Director | Repare Therapeutics Inc. (RPTX) | 29-Dec-22 | Acquisition (other) | 1,240 | -- | -- | < 1% 3.38M to 3.38M | |
| 03-Jan-23 4:38 PM View: | Jerel Davis Director | Repare Therapeutics Inc. (RPTX) | 29-Dec-22 | Disposition (other) | 397,888 | -- | -- | (12%) 3.39M to 2.99M | |
| 03-Jan-23 4:38 PM View: | Jerel Davis Director | Repare Therapeutics Inc. (RPTX) | 29-Dec-22 | Acquisition (other) | 4,721 | -- | -- | < 1% 3.38M to 3.39M | |
| 03-Jan-23 4:38 PM View: | Jerel Davis Director | Repare Therapeutics Inc. (RPTX) | 29-Dec-22 | Acquisition (other) | 65,957 | -- | -- | 2% 3.32M to 3.38M | |
| 03-Jan-23 4:38 PM View: | Jerel Davis Director | Repare Therapeutics Inc. (RPTX) | 29-Dec-22 | Acquisition (other) | 3,014 | -- | -- | < 1% 3.39M to 3.39M | |
| 20-Dec-22 8:05 PM View: | Koehler Maria EVP, Chief Medical Officer | Repare Therapeutics Inc. (RPTX) | 20-Dec-22 | Option Exercise | 48,507 | $2.06 | $100,040.00 | 48% 101.01K to 149.51K | |
| 13-Dec-22 4:18 PM View: | Jerel Davis Director | Repare Therapeutics Inc. (RPTX) | 09-Dec-22 | Market Sale | 250,000 | $16.00 | $4,000,000.00 | (7%) 3.57M to 3.32M | < 1% |
| 15-Jun-22 6:15 PM View: | Bvf Partners L P/il 10% Owner | Repare Therapeutics Inc. (RPTX) | 13-Jun-22 | Private Purchase | 149,161 | $12.73 | $1,898,820.00 | 2% 8.01M to 8.16M | |
| 07-Jun-22 4:32 PM View: | Jerel Davis Director 10% Owner | Repare Therapeutics Inc. (RPTX) | 06-Jun-22 | Acquisition (other) | 2,653 | -- | -- | < 1% 4.4M to 4.4M | |
| 07-Jun-22 4:32 PM View: | Jerel Davis Director 10% Owner | Repare Therapeutics Inc. (RPTX) | 06-Jun-22 | Disposition (other) | 851,202 | -- | -- | (19%) 4.42M to 3.57M | |
| 07-Jun-22 4:37 PM View: | Versant Vantage I, L.P. 10% Owner | Repare Therapeutics Inc. (RPTX) | 06-Jun-22 | Disposition (other) Duplicate | 851,202 | -- | -- | (19%) 4.4M to 3.54M | |
| 07-Jun-22 4:36 PM View: | Versant Ventures V, LLC 10% Owner | Repare Therapeutics Inc. (RPTX) | 06-Jun-22 | Disposition (other) | 653,247 | -- | -- | (15%) 4.4M to 3.74M | |
| 07-Jun-22 4:32 PM View: | Jerel Davis Director 10% Owner | Repare Therapeutics Inc. (RPTX) | 06-Jun-22 | Acquisition (other) | 10,099 | -- | -- | < 1% 4.4M to 4.41M | |
| 07-Jun-22 4:36 PM View: | Versant Ventures V, LLC 10% Owner | Repare Therapeutics Inc. (RPTX) | 06-Jun-22 | Acquisition (other) | 141,103 | -- | -- | 3% 4.24M to 4.39M | |
| 07-Jun-22 4:36 PM View: | Versant Ventures V, LLC 10% Owner | Repare Therapeutics Inc. (RPTX) | 06-Jun-22 | Disposition (other) | 141,103 | -- | -- | (4%) 3.74M to 3.6M |
